Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer

Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer which does not respond to hormone therapy. Research of NEPC has been hampered by a lack of clinically relevant in vivo models. Recently, we developed a first-in-field patient tissue-derived xenograft model of complete...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lin, Dong, Dong, Xin, Wang, Kendric, Wyatt, Alexander W., Crea, Francesco, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Bell, Robert H., Haegert, Anne, Brahmbhatt, Sonal, Hurtado-Coll, Antonio, Gout, Peter W., Fazli, Ladan, Gleave, Martin E., Collins, Colin C., Wang, Yuzhuo
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359333/
https://ncbi.nlm.nih.gov/pubmed/25544761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados